Graft Versus Host Disease
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
8 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 17 trials with date data
Clinical Trials (17)
Total enrollment: 2,025 patients across 17 trials
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
Tissue Repair in Stem Cell Transplant Recipients